Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(12/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(12/week)
News
United States
(492/week)
Manufacturing
(332/week)
Energy
(271/week)
Technology
(348/week)
Other Energy
(234/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Orphan drugs
May 30, 2019
Rare Disease Patient Candace Lerman Calls for Clinical Trials on Off-Label Treatments; Launches ITP Patient Driven Research Initiative
May 30, 2019
U.S. FDA Approves Supplemental New Drug Application Adding Overall Survival Data for XOSPATA® (gilteritinib)
May 29, 2019
DARZALEX® (daratumumab) Phase 3 MAIA Study Results, Published in The New England Journal of Medicine, Show Combination Therapy Increases Progression-Free Survival in Newly Diagnosed Patients with Multiple Myeloma Who are Transplant Ineligible
May 29, 2019
GT Biopharma GTB-1550 PHASE I-II Results to be Published in Conjunction With 2019 ASCO Meeting May 31 - June 4 in Chicago
May 28, 2019
Global Orphan Drugs (Biologics, and Non-Biologics) Markets, 2016-2019 & 2024 - Select Product Approvals/Launches, Recent Industry Activity, & Focus on Key Players
May 16, 2019
Abstract Highlighting New Data from the Iomab-B Pivotal Phase 3 SIERRA Trial to be Presented at 2019 ASCO Annual Meeting
May 16, 2019
Oncopeptides Announces Acceptance of Four Abstracts Highlighting Melflufen Clinical Programs for Presentation at 24th EHA Congress in June 2019
May 16, 2019
Tolero Pharmaceuticals to Highlight Clinical Data Evaluating Investigational Agent Alvocidib in Patients with Newly Diagnosed AML at EHA 2019
May 14, 2019
FDA Approves BAVENCIO® (avelumab) Plus INLYTA® (axitinib) Combination for Patients with Advanced Renal Cell Carcinoma
May 07, 2019
Actinium Announces Appointment of Niva Almaula, Ph.D. as Chief Business Officer
Apr 25, 2019
GT Biopharma (GTBP) to Broadcast Update on TriKE Initiatives for HIV and Oncology at University of Minnesota On May 7th; Dr. Jeff Miller And Dr. Timothy Schacker to Host Event
Apr 25, 2019
Gaucher Disease Drugs Market Size Worth $1.71 Billion by 2025: Grand View Research, Inc.
Apr 08, 2019
GT Biopharma Receives Institutional Review Board Approval to Proceed With in Human FDA Phase 1 Clinical Trial
Apr 08, 2019
Actinium's Leading Clinical, Preclinical, Production and IP Efforts Related to Actinium-225 Highlighted at Preeminent Targeted Alpha Therapy International Symposium
Apr 03, 2019
Actinium Highlights Actimab-A and Venetoclax Synergies Observed in New Studies Presented at AACR
Mar 26, 2019
Janssen Submits Application for DARZALEX® (daratumumab) Combination Therapy to U.S. FDA for Newly Diagnosed, Transplant Eligible Patients with Multiple Myeloma
Mar 19, 2019
Merck KGaA, Darmstadt, Germany, and Pfizer Announce Discontinuation of Phase III JAVELIN Ovarian PARP 100 Trial in Previously Untreated Advanced Ovarian Cancer
Mar 19, 2019
AbbVie Provides Update on VENCLEXTA®/VENCLYXTO® (venetoclax) Multiple Myeloma Program
Mar 14, 2019
Infinity To Initiate MARIO-3, A Phase 2 Multi-Arm Study Evaluating IPI-549 In Front-Line Triple Negative Breast Cancer And Renal Cell Cancer
Mar 14, 2019
Infinity Pharmaceuticals Reports Full Year 2018 Financial Results and Provides Company Update
‹‹
Page 7
››
Latest News
Apr 18, 2024
Argonne’s Decarbonization Scenario Model Analyzes Ambitious Pathways to Net-Zero Carbon Emissions
Apr 18, 2024
Pinnacle West Declares Quarterly Dividend
Apr 18, 2024
Gulfport Energy Schedules First Quarter 2024 Earnings Release and Conference Call
Apr 18, 2024
Entegris to Report Results for First Quarter of 2024 on Wednesday, May 1, 2024
Apr 18, 2024
NRG Energy, Inc. Announces Quarterly Dividend
Apr 18, 2024
Fluor Selected for Position on Global Contingency Services Multiple Award Contract III
Apr 18, 2024
Southwestern Energy Schedules First Quarter Earnings Release Date for May 2, 2024
Apr 18, 2024
Luxfer Announces Date of First Quarter 2024 Earnings Conference Call
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events